Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Cullinan Therapeutics (CGEM) Q4 2023 Earnings
CGEM
14
Mar
Confirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-1.42
-1.13
-0.83
-0.54
Details
Expected EPS
-0.961429
Actual EPS
-0.54
Surprise EPS
0.42
Surprise Percent
+43.83%
Description
Cullinan Therapeutics (CGEM) has reported earnings of -0.54 per share for Q4 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login